Wolverine Asset Management’s Humacyte Inc Warrant HUMAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.47K Buy
37,975
+1,115
+3% +$128 ﹤0.01% 1514
2025
Q4
$3.45K Sell
36,860
-13,151
-26% -$2.52K ﹤0.01% 1503
2025
Q3
$13.3K Buy
50,011
+18,162
+57% +$6.21K ﹤0.01% 1340
2025
Q2
$12.7K Sell
31,849
-2,862
-8% -$1.24K ﹤0.01% 1358
2025
Q1
$12.8K Buy
34,711
+2,676
+8% +$3.33K ﹤0.01% 1284
2024
Q4
$58.3K Sell
32,035
-28,381
-47% -$50.3K ﹤0.01% 1180
2024
Q3
$108K Sell
60,416
-20,138
-25% -$44.4K ﹤0.01% 1099
2024
Q2
$112K Buy
+80,554
New +$99.9K ﹤0.01% 1078
2024
Q1
Sell
-8,260
Closed -$3.44K 1775
2023
Q4
$3.44K Buy
8,260
+7,479
+958% +$3.67K ﹤0.01% 1514
2023
Q3
$560 Buy
+781
New +$610 ﹤0.01% 1747
2021
Q4
Sell
-2,959
Closed -$8K 2121
2021
Q3
$8K Buy
+2,959
New +$8.67K ﹤0.01% 1795
2021
Q1
Sell
-20,244
Closed -$23K 2128
2020
Q4
$23K Buy
+20,244
New +$19.1K ﹤0.01% 1432

Other funds holding HUMAW

Wolverine Asset Management's HUMAW Position: Q1 2026 in Review

Wolverine Asset Management increased its Humacyte Inc Warrant (HUMAW) stake by 3% in Q1 2026, buying an estimated $128 and bringing the position to 37,975 shares worth $3.47K. The position accounts for ﹤0.01% of the portfolio, ranked #1514.

Wolverine Asset Management first reported a position in HUMAW in Q4 2020 and has held it in 12 quarters since. The position peaked at $112K in Q2 2024. 7 funds tracked by Wall St. Rank hold HUMAW as of Q1 2026.

  • Wolverine Asset Management held 37,975 shares of Humacyte Inc Warrant worth $3.47K as of Q1 2026.
  • Wolverine Asset Management bought 1,115 Humacyte Inc Warrant shares in Q1 2026, an estimated $128.
  • Humacyte Inc Warrant made up ﹤0.01% of Wolverine Asset Management's portfolio in Q1 2026, its #1514 holding.
  • Wolverine Asset Management first reported a position in Humacyte Inc Warrant in Q4 2020 and has held it in 12 quarters since.
  • Wolverine Asset Management's Humacyte Inc Warrant position peaked at $112K in Q2 2024.
  • 7 funds tracked by Wall St. Rank held Humacyte Inc Warrant as of Q1 2026.

Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.